Founded in 1993, Capricorn Partners is an asset manager based in Belgium. The firm makes investment through technology based growth companies.

Capricorn Venture Partners

Senior Associate

Partner, Member Executive Committee - Quoted Equity, Finance and General Administration

Senior Investment Manager

Partner

Executive Director CHF

Investment Manager

Chairman Executive Committee - Venture Capital, IT

Investment Associate

Neosens raised $3705531 on 2008-02-25 in Venture Round

Neosens SA engages in the design and development of sensor solutions and technologies to monitor and control water and industrial liquids. It offers sensors that monitor the presence of dissolved oxygen in liquid environments; and fouling systems for continuous fouling monitoring in liquid environments. The companyâ€™s solutions are used in various water and environmental applications, including cooling systems, heat exchangers, potable water, ultra-pure waters, and industrial boilers, as well as in food and beverage, pharmaceutical, pulp and paper, oil, gas, and petrochemical industries. 

The company was founded in 2001 and is based in Labege, France.

Neosens

Nexstim raised $1116466 on 2018-06-18 in Post-IPO Equity

Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.

The company was founded in 2000 and is headquartered in Helsinki, Southern Finland.

Nexstim Plc

Mainstay Medical raised $20000000 on 2012-09-25 in Series B

Mainstay Medical Holdings plc, together with its subsidiaries, operates as a medical device company in Ireland, the United States, and Australia. It focuses on developing and commercializing ReActiv8, an implantable neurostimulation system designed to treat people with chronic low back pain by helping to restore control to the muscles that dynamically stabilise the lumbar spine. Mainstay Medical Holdings plc was founded in 2008 and is headquartered in Dublin, Ireland.

Mainstay Medical

Fluxome raised $20412200 on 2008-07-23 in Series B

Fluxome is a global supplier of natural ingredients with beneficial effects to the human health. They believe that their unique technology and their focused efforts towards developing safe and natural nutraceutical ingredients from a secure and renewable source can help make a difference for their customers.

Fluxome

NovoPolymers raised $3998874 on 2009-05-06 in Series A

NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

NovoPolymers NV

Arkite NV raised $1887440 on 2017-10-16 in Venture Round

Arkite NV manufactures automation products, Human Interface Mate, which assists the manufacturing operator by warning as soon as a wrong operation is in progress and navigates towards standardized work. The company was founded in 2015 and is based in Genk, Belgium.

Arkite NV

TROD Medical raised $6558454 on 2013-10-25 in Series B

Trod Medical S.A. operates as a medical equipment and surgical device manufacturer. The company was founded in 2006 and is based in Paris, France.

TROD Medical

EclecticIQ raised $24141614 on 2020-12-01 in Series C

EclecticIQ is a global threat intelligence, hunting and response technology provider. Its clients are some of the most targeted organizations, globally. To build tomorrow’s defenses today, they have to understand the threats against them – and align their efforts and investments to mitigate their risks. 

EclecticIQ helps governments, large enterprises and service providers manage threat intelligence, create situational awareness and adopt an intelligence-led cybersecurity approach. EclecticIQ extended its focus towards hunting and response with the acquisition of Polylogyx’s endpoint technology in 2020. Founded in 2014, EclecticIQ operates globally with offices across Europe, North America, and via value-add partners. 

More info: www.eclecticiq.com

EclecticIQ

Gradyent raised $2140635 on 2020-06-16 in Seed Round

Gradyent B.V. designs and develops cloud-based artificial intelligence (AI) software that supports the management and optimization of district heating networks. Its platform uses digital twin technology that uses combination of hydro and thermodynamic modeling with AI to optimize and forecast the heating network in real time and detect any changes in it. The company primarily caters to district heating companies. Gradyent B.V. was founded in 2019 and is based in Utrecht, the Netherlands with research and development centre in The Hague, the Netherlands.

Gradyent

EclecticIQ raised $23412870 on 2020-09-22 in Series C

StoryChief raised $3452905 on 2022-07-18 in Venture Round

StoryChief.io is an Editorial Software for Startups, SEO Marketers and Editorial teams who want to publish their stories multi-channel in seconds. 

This tool lets you create and push your articles to different publishing channels like Wordpress, Self hosted SC blog, API, Accelerated Mobile Pages (Apple News, Facebook Instant Articles, Google AMP, ...), Medium.com, Newsletters, Ambassadors, Press contacts/Influencers, etc.  

It has a universal editor that lets you create beautiful stories with ease, making them look as they should on these channels and measure your impact and ROI in one place. It also provides SEO suggestions for your content.

StoryChief

NGDATA raised $3300000 on 2013-09-24 in Series A

NGDATA develops data management systems. The company offers Lily, a big data management system that extracts business insights in real-time and benefits from enriched data in real-time. It serves retail and e-commerce; news, publishing, and media; finance, credit, and insurance; and telecom domains. The company is based in Ghent, Belgium with an additional office in Singapore; and Paris, France.

NGDATA

Green Biologics raised $5115727 on 2012-05-16 in Venture Round

Green Biologics is a revenue generating industrial biotech company based in Oxfordshire aiming to become the world's leading supplier of advanced fermentation technologies for conversion of biomass to renewable fuels and chemicals.

Green Biologics

MAPPER Lithography raised $510000 on 2007-05-30 in Series B

MAPPER Lithography B.V. develops a maskless lithography infrastructure for the semiconductor industry. It offers tools that use multiple e-beam technology for manufacturing semiconductors. The company’s technology is used for making chips without a mask and using electron beams. MAPPER Lithography B.V. was founded in 2000 and is based in Delft, the Netherlands. The company has a manufacturing facility in Moscow, Russian Federation.

MAPPER Lithography B.V.

FRX Polymers raised $15700000 on 2011-06-06 in Series B

FRX Polymers is an industrial company that manufactures Nofia polyphosphonates, a type of fire-resistant plastics. The company is in the growth phase of is commercializing a novel family of non-halogen, transparent, high melt flowing, fire-resistant plastics. It delivers high value-added solutions for fabric/textile, electrical, electronics, mass transit, and building and construction markets. 

FRX Polymers is headquartered in Chelmsford, MA.

FRX Polymers, Inc.

Finquest raised $5500000 on 2022-07-04 in Seed Round

Finquest Pte Ltd.

DMC Biotechnologies raised $11300000 on 2019-12-18 in Series A

DMC Biotechnologies, Inc., a biotechnology company, develops bio-based products using microbial fermentation technology. The company's technology for engineering of microbial hosts enables the production of specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. It develops and deploys Dynamic Metabolic Control technology that reduces the cost and development timeline from discovery to commercial performance. DMC Biotechnologies, Inc. was founded in 2017 and is based in Boulder, Colorado.

DMC Biotechnologies, Inc.

VOID Technologies raised $7319876 on 2020-05-18 in Venture Round

VOID Technologies Limited manufactures and supplies VO+ additive masterbatches to film manufacturers. The company's products are used labels, food packaging, bags, snacks, tapes, and strapping. VOID Technologies Limited was incorporated in 2014 and is headquartered in London, United Kingdom with a manufacturing facility located in Neenah, Wisconsin. VOID Technologies Limited operates as a subsidiary of Kimberly-Clark Corporation.

VOID Technologies

FEops raised $7170000 on 2017-09-22 in Series B

FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians.

Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.

FEops

iSTAR Medical raised $11385112 on 2016-04-12 in Series B

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. 

In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium.

By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

iSTAR Medical

Arcus raised $2000000 on 2014-01-01 in Seed Round

Arcus Financial Intelligence, Inc. develops and operates an application program interface (API) platform for banks and financial institutions that manages consumer bills and financial data. The company provides real-time bill management and payment services. It provides a detailed picture of the family finances of users such as how many bills they have, how much do they owe, and when the bill is due to be paid. The company was formerly known as Regalii Inc. and changed its name to Arcus Financial Intelligence, Inc. in June 2018. Arcus Financial Intelligence, Inc. was founded in 2012 and is based in New York, New York.

Arcus

FEops raised $1509879 on 2015-01-21 in Series A

Capricorn Partners acquires Metallkraft AS on 2012-08-08 for an undisclosed amount

Metallkraft AS processes and recovers silicon carbide, polyethylene glycol, and SiSiCar from spent cutting fluid employed in the production of silicon wafers by the solar and integrated circuitry industries. Its products include slurry recovery, SIC, and glycol; and SiSiCar, a silicon carbide.

Metallkraft AS

Black Bear Carbon raised $5720719 on 2018-11-06 in Venture Round

Black Bear Carbon BV engages in the conversion of waste/end-of-life tires into carbon black and green energy in the Netherlands and internationally. Its carbon black is used for various applications, including tires, technical rubber products, plastics, and paint and ink. The company uses its electricity to power the local operations (tire shredding), as well as delivers to nearby industries or grids. Black Bear Carbon BV was founded in 2010 and is based in Nederweert, the Netherlands.

Black Bear Carbon

Innovium raised $170000000 on 2020-07-21 in Series F

Innovium, Inc. develops and deploys switching silicon solutions for cloud, enterprise, and edge data centers in the United States and internationally. It offers TERALYNX 7 for large scale public and private cloud; and TERALYNX 5 for ToR, enterprise, Edge, and 5G data centers. The company also provides Network OS, a cloud, OEM, open-source network operating system; open source and standard APIs; and TERALYNX software development kit. Innovium, Inc. was incorporated in 2014 and is headquartered in San Jose, California with a location in Bengaluru, India.

Innovium, Inc.

Green Biologics raised $3039375 on 2013-07-31 in Venture Round

Trinean raised $4900636 on 2012-04-27 in Venture Round

Trinean is a Belgium based technology provider, bringing micro-volume molecular spectroscopy to the next level by combining best in class analytical software with a highly standardized read-out platform. Founded in 2006 as a spin-out of the Ghent University, Belgium and Imec Leuven, Belgium, the company commercializes UV/VIS spectrometers for biomolecule quantification. The  DropSense™16 and DropSense™96, analyzing up to 16 and 96 samples resp., use microfluidic chips for standardized sample analysis (DropPlates™ and Slides). The Trinean platform is complemented with a software toolbox for improved data interpretation and lab-automation.

Trinean

Ogeda raised $17937923 on 2015-10-02 in Series B

Ogeda SA, a clinical-stage drug discovery company, invents and develops small molecule drugs targeting G-Protein Coupled Receptors. It offers fezolinetant (ESN364), a Phase II clinical development product for the treatment of women’s health disorders; NK3 antagonists for the treatment of hormone-dependent pathologies in women's health; and products for endocrine, CNS/inflammatory disorders. Ogeda SA was formerly known as Euroscreen SA and changed its name to Ogeda SA in October 2016. The company was founded in 1994 and is based in Gosselies, Belgium. It has a meeting facility in Brussels, Belgium; and an additional office in Paris, France. Ogeda SA operates as a subsidiary of Astellas Pharma Inc.

Ogeda

icometrix raised $18000000 on 2019-05-14 in Series A

Icometrix develops automated magnetic resonance imaging (MRI) biomarkers. The company offers icobrain ms that track disease progression in individual multiple sclerosis patients; cobrain dm that quantifies brain structures in individual dementia patients; and icobrain tbi, which tracks axonal injuries in individual head trauma patients. It also provides services in the areas of CT and advanced MRI. The company is based in Leuven, Belgium.

icometrix NV

FRX Polymers raised $22000000 on 2016-09-13 in Series D

Prolupin GmbH raised an undisclosed amount on 2020-03-17 in Venture Round

Prolupin GmbH is a spin-off from the Fraunhofer Institute for Process Engineering and Packaging IVV in Freising. The world-leading expertise on the fractionation of lupines and the application of this in food technology gives the business a strong position in the vegetable protein market. This position is secured by several Fraunhofer patents. 

The company's business activities focus on developing, producing and marketing vegetable-based, lactose-free milk substitutes from the blue sweet lupine (Lupinus angustifolius). This domestic legume is particularly rich in proteins, undemanding with regard to soil and climate and grows predominantly in Northern Germany (soybean of the north), Poland, Scandinavia, North America and Australia. With the processing technologies developed at Fraunhofer IVV, it is possible to adapt the lupine protein flavor profile in such a way as to achieve a milk-like taste.

Prolupin GmbH

Zozio raised $4225328 on 2022-05-09 in Seed Round

Zozio

Miaa Guard raised $3417000 on 2019-01-03 in Venture Round

miaa Guard CVBA develops a platform that implements access control solutions to monetise digital business with microservice APIs. The platform offers API and introduces a access model to respond to identities of consumers and professionals within an enterprise's context, access rights and policies for an enterprise's digital assets, and authorisations granted by users to other users. It provides services, including security and access governance; integration and data architecture; and configuration and customisation. miaa Guard CVBA was formerly known as VintiQ and changed its name to miaa Guard CVBA in 2014. The company was founded in 2009 and is based in Leuven, Belgium.

miaa Guard CVBA

Indigo Diabetes raised $7273558 on 2016-12-20 in Series A

Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology that revolutionized the Internet during the last decades and now aims at transforming diabetes management.

Indigo Diabetes

EpiGaN raised $5664807 on 2011-07-14 in Venture Round

EpiGaN, a Leuven, Belgium-based company that develops Gallium Nitride on Silicon (GaN) on-silicon wafers...

EpiGaN

Neosens raised $5320000 on 2009-03-31 in Series B

LindaCare raised $8564220 on 2018-01-18 in Series B

LindaCare's mission is to help you reduce cost of delivery of care, improve quality of care and patient safety, for chronic disease management, by simplifying patient tele-monitoring.

By providing healthcare professionals and hospitals with a single integrated and unified vendor independent software platform, LindaCare makes patient tele-monitoring significantly more efficient and improves the quality of patient care.

LindaCare

Noona Healthcare raised $1581694 on 2016-11-23 in Seed Round

Noona is a mobile service that provides cancer centers a real-time holistic view of their patients’ wellbeing. Noona improves the quality of cancer patient care and makes the patient-clinic relationship more personal and meaningful. Clinical staff can rapidly respond to severe symptoms and provide better care to far greater numbers of patients. Noona also enables patients to follow their own wellbeing and recovery and stay in close contact with their clinic.

Noona Healthcare

NovoPolymers raised $5736027 on 2011-02-03 in Series B

Anteryon raised $1190000 on 2010-06-07 in Venture Round

Anteryon B.V. designs and manufactures high-tech optical solutions. It offers micro-optics solutions, such as camera modules, stacked wafers, and lens wafers; lenses, including aspheric lenses, lens arrays, free form lenses, and lenticulars; lasers that comprise diode laser modules, fiber collimators, and assemblies; and planar optics, which include substrates, precision optics, optical coatings, and powder blasting. The company serves semiconductor lithography, measurement equipment, data storage, and optical media markets. Anteryon B.V. was formerly known as Philips Optics and changed its name to Anteryon B.V. in 2006. The company was founded in 1943 and is based in Eindhoven, the Netherlands. Anteryon B.V. operates as a subsidiary of Anteryon International B.V.

Anteryon

Ensartech raised an undisclosed amount on 2008-06-17 in Venture Round

Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

Ensartech

Liquidity Nanotech Corporation raised $8376852 on 2011-10-20 in Series A

Liquidity manufactures breakthrough water purification cartridges, based on revolutionary membrane nanoscience, to solve the world's potable water needs. Pour any non-salt water through their cartridge and drink it safely. It's that simple. No chemicals, no power nor pressure. Their product will save millions of lives currently lost to preventable waterborne diseases.

Liquidity Nanotech Corporation

Black Bear Carbon raised $6078872 on 2021-05-17 in Venture Round

SpaceX raised $1000000000 on 2015-01-20 in Series G

Space Exploration Technologies is a space-transportation startup company founded by Elon Musk. SpaceX designs, manufactures, and launches advanced rockets and spacecraft. SpaceX develops crew and cargo capsules, engines, cryogenic tank structures, avionics, equipment, guidance, and control software. The company is developing the partially reusable launch vehicles Falcon 1 and Falcon 9.

Founded in 2002, Space Exploration Technologies is headquartered in Hawthorne, California.

SpaceX, Inc.

c-LEcta raised an undisclosed amount on 2018-08-23 in Venture Round

c-LEcta GmbH operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. The company develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. It offers DENARASE, a genetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. c-LEcta GmbH was founded in 2004 and is based in Leipzig, Germany.

c-LEcta GmbH

Mendel Biotechnology raised $8387128 on 2007-06-13 in Series D

Mendel Biotechnology, Inc. operates as a plant biotechnology company. The company focuses on developing genetic and chemical solutions for a range of agricultural markets. It offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company has strategic partnerships with Monsanto Corporation, BP, and Bayer CropScience. Mendel Biotechnology, Inc. was founded in 1997 and is based in Hayward, California. It has operations in the United States, Europe, and China.

Mendel Biotechnology

Gradyent raised $10169908 on 2022-08-16 in Series A

Bingli raised $5337851 on 2022-10-04 in Series A

Bingli

iSTAR Medical raised $44137979 on 2019-09-05 in Series C

Chainels raised $3259367 on 2023-01-24 in Series A

CHAINels is a web based Business Platform providing a tailored communication and management tool for groups of SMEs.

CHAINels offers an integral and low-cost solution to
consolidate and facilitate communication between Business Interest group members, group management
and the outside world.
Using the most recent technology, CHAINels provides its customers with advanced tools to drastically increase the economic value of their Business Interest group.

CHAINels platform is a fully web-based alternative to SAAS and Intranet custom made tools aimed at business interest groups. CHAINels aims to build a single environment offering both Intranet and Internet benefits to its users.

The services are delivered through web-based platform for organizations, business groups, and companies where they can connect and interact with each other by establishing mutual links (chains). For business groups sharing the same interest, CHAINels offers tailored management, communication and identity maintenance solutions. For group members – the SMEs, the platform becomes a vessel of on line business presence, combining the functionality of a dynamic business directory with traits of a traditional business network.

CHAINels

CoreOptics raised $25000000 on 2008-04-01 in Venture Round

CoreOptics is the leading providers of 10G and 40G Distortion Tolerant Transponder Modules and IC solutions for Metro, Regional and Long Haul optical & data networking markets.With a belief that optical communications networks must become open systems that economically transmit information regardless of data rate or fiber types, CoreOptics provides the only field-proven MLSE-based equalization solutions on the market today. This innovative technology helps Tier 1 systems vendors and carriers deploy the next generation of high-performance networks using their existing fiber infrastructure.

CoreOptics' 10G and 40G Distortion Tolerant Transponder Modules eliminate the need for Optical Compensators and the respective Second Stage Amplifiers, allowing customers to reduce their first-in deployment cost by up to 30%.

CoreOptics

Ducatt raised $26252817 on 2010-12-20 in Venture Round

Ducatt NV, a Belgium-based solar-glass start-up.

Ducatt

Virovet raised $6647249 on 2020-05-28 in Series B

ViroVet NV develops virus control solutions for the livestock industry. It offers antiviral drugs for the control and treatment of respiratory diseases of cattle and swine. The company also offers modified live virus vaccines for endemic and epizootic viral livestock diseases. ViroVet NV was founded in 2015 and is based in Leuven, Belgium.

Virovet

Confo Therapeutics raised $33568762 on 2019-05-07 in Series A

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO® technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO® body-stabilized active state conformations of these receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.

Confo Therapeutics

NovoPolymers raised an undisclosed amount on 2015-07-08 in Venture Round

DMC Biotechnologies raised $1166000 on 2018-01-04 in Seed Round

Ensartech raised an undisclosed amount on 2011-01-26 in Venture Round

Sequana Medical raised $26079729 on 2014-04-25 in Series C

Sequana Medical NV, a commercial stage medical device company, focuses on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure in Switzerland, Germany, and internationally. Its products include alfapump, a treatment solution for the management of liver refractory ascites and malignant ascites; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with volume overload due to heart failure. The company was founded in 2006 and is headquartered in Ghent, Belgium.

Sequana Medical NV

Sensolus raised $4108029 on 2020-10-06 in Venture Round

Sensolus NV designs and develops global positioning system (GPS) trackers that allows to track non-powered assets. It offers turnkey solutions for wireless and low-power context-aware sensing. The company also provides a web based platform, Internet of things (IoT) cloud platform, and application that helps to provide real time information about assets. It serves manufacturing, waste management, cargo transport, transport and logistics, and automotive industry. The company was founded in 2013 and is based in Ghent, Belgium.

Sensolus

Equator Technologies, Inc. raised $40000000 on 2000-11-13 in Series D

Equator Technologies, Inc. is a provider of system-on-a-chip processors for video streaming and image processing applications.

Equator Technologies, Inc.

FRX Polymers raised $12000000 on 2014-01-15 in Series C

TiGenix raised $14041591 on 2003-10-02 in Venture Round

TiGenix NV (TiGenix) and its subsidiaries TiGenix Inc. and TC CEF LLC. is a Belgium-based biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. The Company is exploiting the power of regenerative medicine for the development of durable treatments, validated through controlled clinical studies, for these indications. TiGenix is located in Leuven and was founded as a spin-off of the Catholic University of Leuven and the University of Ghent. TiGenix is developing a portfolio of products that addresses specific musculoskeletal problems. The lead indication among these is cartilage damage, which is a debilitating affliction severely affecting the mobility and functioning of patients. During the fiscal year ended December 31, 2009, the Company acquired Orthomimetics Ltd.

TiGenix NV

Green Biologics raised $42000000 on 2015-01-21 in Series C

Virovet raised an undisclosed amount on 2017-10-06 in Series A

Diagenode raised $8487014 on 2016-06-20 in Venture Round

Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office in the United Kingdom to better serve this specific country.
Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies.
Epigenetics Division

Diagenode s.a.

Avantium Technologies raised $52490993 on 2014-05-22 in Series G

Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands.

Avantium's proprietary high-throughput technology enables a faster and more cost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development.

Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields:

new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent.

Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business.

Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.

Avantium N.V.

Certess raised $2000000 on 2007-12-21 in Venture Round

Certess is the only electronic design automation (EDA) company providing functional qualification products for companies that create and integrate complex design blocks or intellectual property (IP). Most advanced functional verification teams currently use a combination of techniques to gain visibility into the question of verification quality only to constantly fall short of the ability to truly qualify designs.

Although verification engineers have dedicated tools and methodologies for verification quality improvement, functional logic errors still remain the largest causes of chip respins.

They provide design and verification engineers with an objective way to evaluate and improve the completeness of the verification environment, resulting in a shorter and more predictable process to integrate SoC designs and ensure high quality designs.

The company was incorporated in 2005 and was based in Campbell, California.  

In March 2009, Certess was acquired by SpringSoft, LLC.

Certess

Welcome Real Time raised $620000 on 2005-05-03 in Venture Round

Welcome Real-time S.A. provides credit and debit card acceptance, and payment integrated value-added service solutions for the banks, retailers, merchants, and financial organizations. Its products include XLS Server, which adds EMV capabilities to a bank's payment authorization and processing system; XLS POS that includes software libraries used by POS developers to create full featured payment applications; XLS Card, which includes personalization specifications and card applets used to add payment parameters and data next to EMV risk parameters, and data during the card issuance process; CardCare that provides card activity reporting and card's contents to facilitate cardholder services, such as card replacements and cardholder inquiries through a bank's Website or call centre; and MerchantCare, which provides a bank's merchant services with merchant activity reporting, as well as a view of merchant's transaction activity and payment parameter settings. The company was founded in 1996 and is headquartered in Aix-en-Province, France with additional offices, and research and development facilities in Singapore, Singapore; Madrid, Spain; Miami, Florida; Shanghai, China; and Sao Paulo, Brazil.

Welcome Real Time

Sequana Medical raised $25513252 on 2011-03-09 in Series B

NGDATA raised $19000000 on 2017-12-05 in Series C

Metallkraft AS raised $32540000 on 2008-12-18 in Series A

NGDATA raised $10200000 on 2015-10-28 in Series B

Green Biologics raised $25186980 on 2013-12-02 in Series B

Sensolus raised $3253590 on 2017-10-12 in Seed Round

Avantium Technologies raised $18000000 on 2008-10-29 in Venture Round

Nexstim raised $2849550 on 2011-05-11 in Venture Round

Gemidis raised $8080000 on 2006-03-27 in Series C

Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

Gemidis

Sequana Medical raised $9268661 on 2015-10-23 in Series C

iNEWiT raised $3150000 on 2008-03-06 in Venture Round

iNEWiT, an engineering company, engages in identifying, designing, and creating applications and devices for the mobile market. It provides mobile video communication applications; wireless communication technologies, ranging from GPRS/EDGE, over 3G, HSDPA/HSUPA to WiFi, and WiMAX and satellite networks; and plug and play products for the business-to-consumer markets. 

The company was founded in 2005 and is based in Mechelen, Belgium

iNEWiT

NovoPolymers raised $7130915 on 2012-03-21 in Venture Round

Bluebee raised $11380098 on 2016-03-31 in Series A

Bluebee Holding B.V. develops cloud-based accelerated genomics analysis platform that enables processing of sequencing data. The company’s Bluebee genomics platform supports cross-functional teams of life science researchers and clinicians in processing, managing, and sharing sequence data. The company also offers data analytics and aggregation and customized user experience. It serves research centers, sequencing service providers, clinical labs, and kit providers. The company was founded in 2011 and is based in Rijswijk, the Netherlands. As of June 17, 2020, Bluebee Holding B.V. operates as a subsidiary of Illumina, Inc.

Bluebee Holding B.V.

Arkite NV raised $1705725 on 2019-06-27 in Venture Round